Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant Recipients

NCT03470961 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

CKD (Chronic Kidney Disease) Stage 5T
Diabetes Mellitus
Simultaneous Pancreas Kidney Transplantation

Interventions

DRUG: Anti-Tlymphocyte Globulins
DRUG: Anti-Thymocyte Globulins

Sponsor

Tianjin First Central Hospital